We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+1.64%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$726M
AUM Growth
+$25.3M
Cap. Flow
+$18.4M
Cap. Flow %
2.53%
Top 10 Hldgs %
78.07%
Holding
26
New
–
Increased
9
Reduced
7
Closed
1

Top Buys

Rank Stock Value
1
PGEN icon
Precigen
PGEN
+$11.6M
2
NXTM
NxStage Medical Inc.
NXTM
+$10.8M
3
VRML
Vermillion, Inc.
VRML
+$10.6M
4
BIOL
Biolase, Inc.
BIOL
+$6.59M
5
TSRO
TESARO, Inc.
TSRO
+$3.38M

Top Sells

Rank Stock Value
1
MAKO
MAKO SURGICAL CORP COM
MAKO
+$23.9M
2
THOR
THORATEC CORPORATION
THOR
+$6.42M
3
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$1.18M
4
ACOR
Acorda Therapeutics
ACOR
+$1.07M
5
OPK icon
Opko Health
OPK
+$768K

Sector Composition

Rank Sector Weight
1 Healthcare 68.42%
2 Consumer Staples 0.29%
3 Financials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVEO
26
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
– –
-57,500
Closed -$1.18M
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Oracle Investment Management held 26 positions worth $726M, up 3.6% from $701M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Trading was light in Q4 2013: portfolio turnover was 3.8%. Oracle Investment Management opened no new positions and exited 1, leaving the 26-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, up from 66% a quarter earlier, followed by Consumer Staples and Financials.

  • Oracle Investment Management added most to Precigen in Q4 2013, an estimated $11.6M increase.
  • Oracle Investment Management's biggest Q4 2013 reduction was MAKO SURGICAL CORP COM, cutting an estimated $23.9M.
  • Oracle Investment Management fully exited AVEO Pharmaceuticals, Inc. in Q4 2013, selling an estimated $1.18M.
  • Oracle Investment Management's ten largest holdings make up 78% of its $726M portfolio in Q4 2013.
  • Oracle Investment Management opened 0 new positions and closed 1 in Q4 2013.
  • Oracle Investment Management's portfolio value rose 3.6% quarter-over-quarter to $726M.

Based on Oracle Investment Management's 13F filing for Q4 2013, filed 14 Feb 2014.